On 15 April 2026, Dr. Reddy’s Laboratories Limited informed stock exchanges that its step down wholly owned subsidiary in Russia Dr. Reddy’s Laboratories LLC has received a final tax order imposing a VAT penalty of approximately Rs 11.4 million (RUB 9.27 million).
Dr. Reddy’s Laboratories one of India’s leading pharmaceutical companies headquartered in Hyderabad, recently made headlines after disclosing GST demand orders totalling approximately ₹2.20 crore for the financial years FY20–22. Reported widely in March 2026, this development highlights the ongoing challenges companies face under India’s complex GST regime even those with strong compliance system.
Read More
